Announcements

Updates on campus events, policies, construction and more.

close  

Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to Washington University School of Medicine.

close  


Visit the News Hub

Wahl honored for leadership in nuclear medicine and imaging

Radiologist developed new cancer therapies, established research fund

July 25, 2024

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently presented the 2024 Minoshima-Pappas Transformative Leadership Award to Richard Wahl, MD, professor of radiology and of radiation oncology at Washington University School of Medicine in St. Louis.

Wahl is only the second recipient of the award, which the SNMMI established to recognize individuals who have brought meaningful improvements to the science and practice of nuclear medicine and molecular imaging.

Wahl, a member of the National Academy of Medicine, practices at Barnes Jewish Hospital and is the former director of the School of Medicine’s Mallinckrodt Institute of Radiology, has contributed to several advances in the field of nuclear medicine and imaging, most notably by developing the first FDA-approved radioimmunotherapies — radioactive compounds that bind specifically to cancerous cells — for non-Hodgkin’s lymphoma. He also pioneered the use of PET imaging to assess a  wide range of cancers.  His work has also resulted in a number of FDA-approved drugs and devices that use radioactive tracing compounds to bind to specific proteins to diagnose and treat cancers.

As past president of SNMMI, Wahl was the driving force behind the creation of the SNMMI Mars Shot Fund. The $100 million fund provides grant support for research in nuclear medicine and molecular imaging that has the potential to improve patient outcomes. The fund started disbursing grants last year and is supporting seven research projects across the country.

About Washington University School of Medicine

WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,900 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 56% in the last seven years. Together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,900 faculty physicians practicing at 130 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children’s hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.